Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Burning Rock Biotech (BNR) Gross Margin: 2019-2025

Historic Gross Margin for Burning Rock Biotech (BNR) over the last 7 years, with Sep 2025 value amounting to 72.79%.

  • Burning Rock Biotech's Gross Margin rose 362.00% to 72.79% in Q3 2025 from the same period last year, while for Sep 2025 it was 73.16%, marking a year-over-year increase of 475.00%. This contributed to the annual value of 70.25% for FY2024, which is 267.00% up from last year.
  • Latest data reveals that Burning Rock Biotech reported Gross Margin of 72.79% as of Q3 2025, which was down 0.22% from 72.95% recorded in Q2 2025.
  • In the past 5 years, Burning Rock Biotech's Gross Margin ranged from a high of 73.19% in Q1 2025 and a low of 63.03% during Q2 2022.
  • Moreover, its 3-year median value for Gross Margin was 69.30% (2023), whereas its average is 70.17%.
  • Its Gross Margin has fluctuated over the past 5 years, first spiked by 565bps in 2021, then tumbled by 787bps in 2022.
  • Over the past 5 years, Burning Rock Biotech's Gross Margin (Quarterly) stood at 71.52% in 2021, then tumbled by 560bps to 65.91% in 2022, then soared by 276bps to 68.68% in 2023, then skyrocketed by 241bps to 71.09% in 2024, then surged by 362bps to 72.79% in 2025.
  • Its Gross Margin was 72.79% in Q3 2025, compared to 72.95% in Q2 2025 and 73.19% in Q1 2025.